Results 131 to 140 of about 76,925 (188)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. [PDF]

open access: yesRMD Open, 2020
Ogdie A   +10 more
europepmc   +1 more source

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. [PDF]

open access: yesRheumatol Ther
Rubbert-Roth A   +9 more
europepmc   +1 more source

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry. [PDF]

open access: yesAnn Rheum Dis
Hernández-Cruz B   +13 more
europepmc   +1 more source

Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. [PDF]

open access: yesTher Adv Musculoskelet Dis, 2020
Tektonidou MG   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy